WeVote

Bill

Bill

HB 2429

Authorizing the over-the-counter purchase of ivermectin and hydroxychloroquine tablets.

2025-2026 Regular Session Introduced by Brett Fairchild

Kansas bill would permit over-the-counter purchase of ivermectin and hydroxychloroquine, eliminating prescription requirements for medications typically requiring medical supervision.

Died in Committee
0
WeVote Research Nonpartisan
Bill Summary · HB 2429

Legislative bill overview

HB 2429 would allow Kansans to purchase ivermectin and hydroxychloroquine tablets without a prescription, converting these currently prescription-only medications to over-the-counter status. The bill was introduced in January 2026 and has been referred to the Health and Human Services Committee for review.

Why is this important

This bill directly affects medication access and regulatory authority over pharmaceuticals. It raises questions about drug safety oversight, as both medications require medical supervision in current practice—ivermectin for parasitic infections and hydroxychloroquine for malaria, lupus, and rheumatoid arthritis. The proposal gained attention partly due to debates over these drugs' use for off-label purposes during the COVID-19 pandemic.

Potential points of contention

  • Drug safety and medical oversight: Both medications can cause serious side effects (liver damage, vision problems, heart rhythm issues) that typically require medical monitoring through blood tests and eye exams
  • Off-label use concerns: Removing prescription requirements may increase use for conditions without established efficacy, particularly given recent public debate over these drugs' effectiveness for certain illnesses
  • Dosing and drug interactions: OTC status eliminates pharmacist and physician review for dangerous medication interactions, especially relevant for hydroxychloroquine used by patients on multiple medications

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.